These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 21491078)
1. Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines. Adler D; Lindstrot A; Langer B; Buettner R; Wernert N Int J Mol Med; 2011 Jul; 28(1):89-93. PubMed ID: 21491078 [TBL] [Abstract][Full Text] [Related]
2. Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells. Adler D; Langer B; Lindstrot A; Florin A; Bosserhoff A; Buettner R; Wernert N Oncol Rep; 2011 Apr; 25(4):1125-9. PubMed ID: 21258770 [TBL] [Abstract][Full Text] [Related]
3. ETS transcription factors and prostate cancer: the role of the family prototype ETS-1 (review). Adler D; Wernert N Int J Oncol; 2012 Jun; 40(6):1748-54. PubMed ID: 22366814 [TBL] [Abstract][Full Text] [Related]
4. Rearrangement of the ETS genes ETV-1, ETV-4, ETV-5, and ELK-4 is a clonal event during prostate cancer progression. Alder D; Braun M; Nikolov P; Boehm D; Scheble V; Menon R; Fend F; Kristiansen G; Perner S; Wernert N Hum Pathol; 2012 Nov; 43(11):1910-6. PubMed ID: 22569213 [TBL] [Abstract][Full Text] [Related]
5. ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer. Adler D; Ochsenfahrt J; Fuchs K; Kristiansen G; Perner S; Wernert N Int J Mol Med; 2012 Nov; 30(5):1029-33. PubMed ID: 22922762 [TBL] [Abstract][Full Text] [Related]
6. Novel identification of the ETS-1 splice variants p42 and p27 in prostate cancer cell lines. Adler D; Ochsenfahrt J; Fuchs K; Wernert N Oncol Rep; 2012 May; 27(5):1321-4. PubMed ID: 22307076 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive gene expression microarray analysis of Ets-1 blockade in PC3 prostate cancer cells and correlations with prostate cancer tissues: Insights into genes involved in the metastatic cascade. Adler D; Lindstrot A; Langer B; Buettner R; Wernert N Int J Mol Med; 2011 Jun; 27(6):811-9. PubMed ID: 21424114 [TBL] [Abstract][Full Text] [Related]
8. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. Rickman DS; Pflueger D; Moss B; VanDoren VE; Chen CX; de la Taille A; Kuefer R; Tewari AK; Setlur SR; Demichelis F; Rubin MA Cancer Res; 2009 Apr; 69(7):2734-8. PubMed ID: 19293179 [TBL] [Abstract][Full Text] [Related]
10. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502 [TBL] [Abstract][Full Text] [Related]
11. ETS factors in prostate cancer. Qian C; Li D; Chen Y Cancer Lett; 2022 Apr; 530():181-189. PubMed ID: 35033589 [TBL] [Abstract][Full Text] [Related]
12. The peripheral zone of the prostate is more prone to tumor development than the transitional zone: is the ETS family the key? Adler D; Lindstrot A; Ellinger J; Rogenhofer S; Buettner R; Perner S; Wernert N Mol Med Rep; 2012 Feb; 5(2):313-6. PubMed ID: 22038307 [TBL] [Abstract][Full Text] [Related]
14. ETS gene fusions in prostate cancer. Clark JP; Cooper CS Nat Rev Urol; 2009 Aug; 6(8):429-39. PubMed ID: 19657377 [TBL] [Abstract][Full Text] [Related]
15. Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer. Berglund AE; Rounbehler RJ; Gerke T; Awasthi S; Cheng CH; Takhar M; Davicioni E; Alshalalfa M; Erho N; Klein EA; Freedland SJ; Ross AE; Schaeffer EM; Trock BJ; Den RB; Cleveland JL; Park JY; Dhillon J; Yamoah K Prostate Cancer Prostatic Dis; 2019 May; 22(2):292-302. PubMed ID: 30367117 [TBL] [Abstract][Full Text] [Related]
16. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. Han B; Mehra R; Dhanasekaran SM; Yu J; Menon A; Lonigro RJ; Wang X; Gong Y; Wang L; Shankar S; Laxman B; Shah RB; Varambally S; Palanisamy N; Tomlins SA; Kumar-Sinha C; Chinnaiyan AM Cancer Res; 2008 Sep; 68(18):7629-37. PubMed ID: 18794152 [TBL] [Abstract][Full Text] [Related]
17. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer. Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932 [TBL] [Abstract][Full Text] [Related]
18. Five ETS family members, ELF-1, ETV-4, ETV-3L, ETS-1, and ETS-2 upregulate human leukocyte-associated immunoglobulin-like receptor-1 gene basic promoter activity. Cao Q; Yang S; Lv Q; Liu Y; Li L; Wu X; Qu G; He X; Zhang X; Sun S; Li B; An J; Hu T; Xue J Aging (Albany NY); 2018 Jun; 10(6):1390-1401. PubMed ID: 29915163 [TBL] [Abstract][Full Text] [Related]
19. Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements. Paulo P; Ribeiro FR; Santos J; Mesquita D; Almeida M; Barros-Silva JD; Itkonen H; Henrique R; Jerónimo C; Sveen A; Mills IG; Skotheim RI; Lothe RA; Teixeira MR Neoplasia; 2012 Jul; 14(7):600-11. PubMed ID: 22904677 [TBL] [Abstract][Full Text] [Related]
20. Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models. Ateeq B; Vellaichamy A; Tomlins SA; Wang R; Cao Q; Lonigro RJ; Pienta KJ; Varambally S Prostate; 2012 Oct; 72(14):1542-9. PubMed ID: 22415461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]